- Home
- VKTX vs GNW Comparison
VKTX vs GNW Comparison
Compare VKTX & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | GNW |
|---|---|---|
| Founded | 2012 | 1871 |
| Country | United States | United States |
| Employees | N/A | 3100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.6B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | VKTX | GNW |
|---|---|---|
| Price | $38.04 | $9.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $95.86 | $10.50 |
| AVG Volume (30 Days) | 2.5M | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $7,301,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $78.42 |
| Revenue Growth | N/A | ★ 0.08 |
| 52 Week Low | $22.96 | $7.13 |
| 52 Week High | $43.15 | $9.45 |
Technical Indicators
Market Signals| Indicator | VKTX | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 73.64 | 69.14 |
| Support Level | $33.65 | $7.97 |
| Resistance Level | $39.78 | N/A |
| Average True Range (ATR) | 1.92 | 0.16 |
| MACD | 1.07 | 0.08 |
| Stochastic Oscillator | 87.55 | 89.45 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.